REVUMENIB

Clinical trials for REVUMENIB explained in plain language.

Never miss a new study

Get alerted when new REVUMENIB trials appear

Sign up with your email to follow new studies for REVUMENIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for tough leukemia: dual attack trial begins

Disease control Not yet recruiting

This early-stage study aims to find a safe and effective dose of two drugs, revumenib and blinatumomab, given together for adults with a specific genetic type of acute lymphoblastic leukemia (ALL). It will enroll about 20 adults, including those newly diagnosed and those whose ca…

Matched conditions: REVUMENIB

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

REVUMENIB

Get alerted when new REVUMENIB trials appear

New hope for tough leukemia: dual attack trial begins